"Calcium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
| Descriptor ID |
D002121
|
| MeSH Number(s) |
D27.505.519.562.249 D27.505.954.411.192
|
| Concept/Terms |
Calcium Channel Blockers- Calcium Channel Blockers
- Blockers, Calcium Channel
- Channel Blockers, Calcium
- Calcium Channel Antagonists
- Antagonists, Calcium Channel
- Calcium Channel Blocking Drugs
Calcium Antagonists, Exogenous- Calcium Antagonists, Exogenous
- Antagonists, Exogenous Calcium
- Exogenous Calcium Inhibitors
- Exogenous Calcium Antagonists
- Exogenous Calcium Blockaders
- Calcium Blockaders, Exogenous
- Calcium Inhibitors, Exogenous
|
Below are MeSH descriptors whose meaning is more general than "Calcium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Calcium Channel Blockers".
This graph shows the total number of publications written about "Calcium Channel Blockers" by people in this website by year, and whether "Calcium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 2 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 2 | 3 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcium Channel Blockers" by people in Profiles.
-
What is the Best Agent for Rate Control of Atrial Fibrillation With Rapid Ventricular Response? J Emerg Med. 2022 Sep; 63(3):467-476.
-
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 08 01; 128:75-83.
-
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage. Stroke. 2020 04; 51(4):1142-1149.
-
The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study. J Hum Hypertens. 2020 11; 34(11):787-794.
-
Emerging Targets for the Management of Osteoarthritis Pain. Curr Osteoporos Rep. 2016 12; 14(6):260-268.
-
Inositol 1,4,5-trisphosphate-mediated sarcoplasmic reticulum-mitochondrial crosstalk influences adenosine triphosphate production via mitochondrial Ca2+ uptake through the mitochondrial ryanodine receptor in cardiac myocytes. Cardiovasc Res. 2016 10; 112(1):491-501.
-
Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study. Int J Impot Res. 2016 Mar-Apr; 28(2):41-5.
-
Comparison of Tamsulosin, Nifedipine, and Placebo for Ureteric Colic. CJEM. 2017 Mar; 19(2):156-158.
-
Intact Heart Loose Patch Photolysis Reveals Ionic Current Kinetics During Ventricular Action Potentials. Circ Res. 2016 Jan 22; 118(2):203-15.
-
Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats. Psychopharmacology (Berl). 2014 May; 231(9):2019-29.